Mirum PharmaceuticalsMIRM
那斯達克 · USD
100.04
+0.51
(+0.51%)
盤中 09/10 01:29 (UTC+8)
09/10 01:29 (UTC+8)
Mirum PharmaceuticalsMIRM
100.04
+0.51
(+0.51%)
財務數據
損益表
- 0.69
- 0.78
- 0.90
- 0.99
- 1.12
- 1.28
- 1.33
- 1.49
- 1.60
- 1.76
- -0.48
- 12.50
- 16.05
- 10.00
- 12.24
- 14.52
- 4.09
- 11.97
- 7.35
- 10.23
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 176,243 | 159,882 | 148,932 | 133,010 | 127,785 | 111,585 | 99,414 | 90,377 | 77,875 | 69,222 |
營業成本 | 30,348 | 28,805 | 28,264 | 25,537 | 23,421 | 23,018 | 22,780 | 20,806 | 20,227 | 17,830 |
營業毛利 | 145,895 | 131,077 | 120,668 | 107,473 | 104,364 | 88,567 | 76,634 | 69,571 | 57,648 | 51,392 |
營業費用 | 188,432 | 920,542 | 125,235 | 104,870 | 109,353 | 98,750 | 100,856 | 82,255 | 81,880 | 77,860 |
研發費用 | 90,528 | 97,910 | 51,107 | 47,960 | 51,067 | 41,044 | 44,026 | 31,710 | 32,672 | 32,222 |
推銷及管理費用 | 81,469 | 96,330 | 74,128 | 61,910 | 63,286 | 57,706 | 56,830 | 50,545 | 49,208 | 45,638 |
非經常性項目費用 | 16,435 | 726,302 | - | -5,000 | -5,000 | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -26,102 | -789,465 | -4,567 | 2,603 | -4,989 | -10,183 | -24,222 | -12,684 | -24,232 | -26,468 |
其他收入及費用 | -20,383 | 3,401 | 3,202 | 3,646 | 3,119 | 5,131 | 3,435 | 2,382 | 3,798 | 5,390 |
利息費用 | 2,618 | 3,616 | 3,598 | 3,606 | 3,589 | 3,596 | 3,579 | 3,586 | 3,569 | 3,577 |
稅前純益 | -65,538 | -789,680 | -4,963 | 2,643 | -5,459 | -13,648 | -24,366 | -13,888 | -24,003 | -24,655 |
所得稅 | 1,689 | 475 | 767 | -262 | 402 | 1,029 | -576 | 347 | 635 | 624 |
稅後純益 | -67,227 | -790,155 | -5,730 | 2,905 | -5,861 | -14,677 | -23,790 | -14,235 | -24,638 | -25,279 |
基本每股稅後盈餘(元) | -1.06 | -13.43 | -0.11 | 0.06 | -0.12 | -0.30 | -0.49 | -0.30 | -0.52 | -0.54 |
稀釋每股稅後盈餘(元) | -0.60 | -13.43 | -0.12 | 0.05 | -0.12 | -0.30 | -0.49 | -0.30 | -0.52 | -0.54 |
基本平均股數(千股) | 63374.00 | 58851.00 | 51896.00 | 50639.00 | 49726.00 | 48889.00 | 48338.00 | 47782.00 | 47235.00 | 46927.00 |
稀釋平均股數(千股) | 63374.00 | 58851.00 | 51896.00 | 56993.00 | 49726.00 | 48889.00 | 48338.00 | 47782.00 | 47235.00 | 46927.00 |
還原基本每股稅後盈餘(元) | -1.06 | -13.43 | -0.11 | 0.06 | -0.12 | -0.30 | -0.49 | -0.30 | -0.52 | -0.54 |
還原稀釋每股稅後盈餘(元) | -0.60 | -13.43 | -0.12 | 0.05 | -0.12 | -0.30 | -0.49 | -0.30 | -0.52 | -0.54 |
還原基本平均股數(千股) | 63,374 | 58,851 | 51,896 | 50,639 | 49,726 | 48,889 | 48,338 | 47,782 | 47,235 | 46,927 |
還原稀釋平均股數(千股) | 63,374 | 58,851 | 51,896 | 56,993 | 49,726 | 48,889 | 48,338 | 47,782 | 47,235 | 46,927 |
EBITDA(千元) | -55,326 | -778,736 | 5,145 | 12,754 | 4,613 | -3,567 | -14,315 | -3,823 | -14,173 | -15,000 |